Literature DB >> 9859924

Genetics of Hb F/F cell variance in adults and heterocellular hereditary persistence of fetal hemoglobin.

S L Thein1, J E Craig.   

Abstract

Hb F and F cell values in normal adults vary considerably with a continuous distribution that is substantially skewed to the right implicating a polygenic influence. The high values of Hb F and F cells are transmitted in the condition referred to as heterocellular hereditary persistence fetal hemoglobin which should be regarded as a multifactorial quantitative trait, quite distinct from the classical pancellular hereditary persistence of fetal hemoglobins. Several factors have been shown to influence F cell/Hb F levels in normal adults including age, gender, genetic determinants linked and unlinked to the beta-globin locus on chromosome 11p. Two trans-acting quantitative trait loci for F cell variance have been mapped, one on 6q and the other on Xp, with at least one other implicated. As an initial step towards hunting for the other quantitative trait loci we have carried out a preliminary analysis of F cell variance in 182 pairs of monozygotic and 373 pairs of dizygotic twins. The correlation coefficient of F cell variance in monozygotic twins was 0.89, while that in the dizygotic twins was 0.51. Overwhelming evidence for a strong genetic component in the control of Hb F/F cell levels is provided by a heritability of 0.87. However, the role and extent of contribution from the quantitative trait loci on 6q and Xp are still not known.

Mesh:

Substances:

Year:  1998        PMID: 9859924     DOI: 10.3109/03630269809071538

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  27 in total

Review 1.  Control of fetal hemoglobin: new insights emerging from genomics and clinical implications.

Authors:  Swee Lay Thein; Stephan Menzel; Mark Lathrop; Chad Garner
Journal:  Hum Mol Genet       Date:  2009-10-15       Impact factor: 6.150

Review 2.  Omics Studies in Hemoglobinopathies.

Authors:  Eleni Katsantoni
Journal:  Mol Diagn Ther       Date:  2019-04       Impact factor: 4.074

3.  Effect of Swiss-type heterocellular HPFH from XmnI-Gγ and HBBP1 polymorphisms on HbF, HbE, MCV and MCH levels in Thai HbE carriers.

Authors:  Sasiwan Kerdpoo; Ektong Limweeraprajak; Thanusak Tatu
Journal:  Int J Hematol       Date:  2014-01-29       Impact factor: 2.490

Review 4.  Sickle cell disease in Africa: burden and research priorities.

Authors:  J Makani; T N Williams; K Marsh
Journal:  Ann Trop Med Parasitol       Date:  2007-01

Review 5.  Beta-thalassaemia prototype of a single gene disorder with multiple phenotypes.

Authors:  Swee Lay Thein
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

Review 6.  Molecular basis of β thalassemia and potential therapeutic targets.

Authors:  Swee Lay Thein
Journal:  Blood Cells Mol Dis       Date:  2017-06-20       Impact factor: 3.039

7.  Genome-wide association study identifies genetic variants influencing F-cell levels in sickle-cell patients.

Authors:  Pallav Bhatnagar; Shirley Purvis; Emily Barron-Casella; Michael R DeBaun; James F Casella; Dan E Arking; Jeffrey R Keefer
Journal:  J Hum Genet       Date:  2011-02-17       Impact factor: 3.172

Review 8.  De novo generation of HSCs from somatic and pluripotent stem cell sources.

Authors:  Linda T Vo; George Q Daley
Journal:  Blood       Date:  2015-03-11       Impact factor: 22.113

9.  The prevalence of maternal F cells in a pregnant population and potential overestimation of foeto-maternal haemorrhage as a consequence.

Authors:  Deirdre Corcoran; Deirdre Murphy; Jennifer C Donnelly; Fionnuala Ni Ainle
Journal:  Blood Transfus       Date:  2013-06-12       Impact factor: 3.443

10.  Developmental and epigenetic regulation of the human TLR3 gene.

Authors:  Analia Porrás; Sarah Kozar; Valya Russanova; Paraskevi Salpea; Tazuko Hirai; Nicholas Sammons; Pooja Mittal; Ji Young Kim; Keiko Ozato; Roberto Romero; Bruce H Howard
Journal:  Mol Immunol       Date:  2008-08-19       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.